PMC:7441788 / 15107-15452
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T97 | 114-122 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CLO
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T171 | 171-173 | http://purl.obolibrary.org/obo/CLO_0053794 | denotes | 41 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T198 | 202-204 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T199 | 271-273 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T123 | 202-204 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
T124 | 271-273 | Chemical | denotes | CQ | http://purl.obolibrary.org/obo/CHEBI_3638 |
LitCovid-sample-PD-NCBITaxon
Id | Subject | Object | Predicate | Lexical cue | ncbi_taxonomy_id |
---|---|---|---|---|---|
T100 | 114-122 | Species | denotes | COVID-19 | NCBItxid:2697049 |
LitCovid-sample-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T111 | 89-170 | Sentence | denotes | In this study, 81 severe COVID-19 patients were randomly divided into two groups: |
T112 | 171-338 | Sentence | denotes | 41 patients received high-dose CQ (600 mg/2 times/day for 10 day) and 40 patients received low-dose CQ (450 mg/2 times on day 1 and then 450 mg/1 time/day for 4 days). |
LitCovid-sample-Pubtator
Id | Subject | Object | Predicate | Lexical cue | pubann:denotes |
---|---|---|---|---|---|
764 | 123-131 | Species | denotes | patients | Tax:9606 |
765 | 174-182 | Species | denotes | patients | Tax:9606 |
766 | 244-252 | Species | denotes | patients | Tax:9606 |
771 | 202-204 | Chemical | denotes | CQ | MESH:D002738 |
772 | 271-273 | Chemical | denotes | CQ | MESH:D002738 |
777 | 114-122 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sample-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T90 | 114-122 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
764 | 123-131 | Species | denotes | patients | Tax:9606 |
765 | 174-182 | Species | denotes | patients | Tax:9606 |
766 | 244-252 | Species | denotes | patients | Tax:9606 |
771 | 202-204 | Chemical | denotes | CQ | MESH:D002738 |
772 | 271-273 | Chemical | denotes | CQ | MESH:D002738 |
777 | 114-122 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T111 | 89-170 | Sentence | denotes | In this study, 81 severe COVID-19 patients were randomly divided into two groups: |
T112 | 171-338 | Sentence | denotes | 41 patients received high-dose CQ (600 mg/2 times/day for 10 day) and 40 patients received low-dose CQ (450 mg/2 times on day 1 and then 450 mg/1 time/day for 4 days). |